These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 34008931)

  • 1. Effect of revascularization on lower extremity muscle function in combined type 2 diabetes and critical limb threatening ischemia.
    Pedersen BL; Helledie G; Eiken FL; Lawaetz J; Eiberg JP; Quistorff B
    Int Angiol; 2021 Aug; 40(4):323-334. PubMed ID: 34008931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischemia.
    Conte MS; Bradbury AW; Kolh P; White JV; Dick F; Fitridge R; Mills JL; Ricco JB; Suresh KR; Murad MH; Aboyans V; Aksoy M; Alexandrescu VA; Armstrong D; Azuma N; Belch J; Bergoeing M; Bjorck M; Chakfé N; Cheng S; Dawson J; Debus ES; Dueck A; Duval S; Eckstein HH; Ferraresi R; Gambhir R; Gargiulo M; Geraghty P; Goode S; Gray B; Guo W; Gupta PC; Hinchliffe R; Jetty P; Komori K; Lavery L; Liang W; Lookstein R; Menard M; Misra S; Miyata T; Moneta G; Munoa Prado JA; Munoz A; Paolini JE; Patel M; Pomposelli F; Powell R; Robless P; Rogers L; Schanzer A; Schneider P; Taylor S; De Ceniga MV; Veller M; Vermassen F; Wang J; Wang S;
    Eur J Vasc Endovasc Surg; 2019 Jul; 58(1S):S1-S109.e33. PubMed ID: 31182334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis of silent coronary ischemia with selective coronary revascularization might improve 2-year survival of patients with critical limb-threatening ischemia.
    Krievins D; Zellans E; Latkovskis G; Kumsars I; Jegere S; Rumba R; Bruvere M; Zarins CK
    J Vasc Surg; 2021 Oct; 74(4):1261-1271. PubMed ID: 33905868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival prediction in patients with chronic limb-threatening ischemia who undergo infrainguinal revascularization.
    Simons JP; Schanzer A; Flahive JM; Osborne NH; Mills JL; Bradbury AW; Conte MS
    Eur J Vasc Endovasc Surg; 2019 Jul; 58(1S):S120-S134.e3. PubMed ID: 31151867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A systematic review and meta-analysis of revascularization outcomes of infrainguinal chronic limb-threatening ischemia.
    Almasri J; Adusumalli J; Asi N; Lakis S; Alsawas M; Prokop LJ; Bradbury A; Kolh P; Conte MS; Murad MH
    Eur J Vasc Endovasc Surg; 2019 Jul; 58(1S):S110-S119. PubMed ID: 31221539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short and long-term outcome after common femoral artery hybrid procedure in patients with intermittent claudication and chronic limb threatening ischemia.
    Woronowicz-Kmiec S; Betz T; Töpel I; Bröckner S; Steinbauer M; Uhl C
    Vasa; 2021 Sep; 50(5):363-371. PubMed ID: 33973817
    [No Abstract]   [Full Text] [Related]  

  • 7. Role of aorto(bi)femoral bypass in treatment of patients with critical limb threatening ischemia.
    Betz T; Toepel I; Pfister K; Steinbauer M; Uhl C
    Surgeon; 2021 Apr; 19(2):103-110. PubMed ID: 32507455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Long Term Outcomes After Endovascular Treatment Versus Bypass Surgery in Chronic Limb Threatening Ischaemia Patients with Long Femoropopliteal Lesions.
    Zlatanovic P; Mahmoud AA; Cinara I; Cvetic V; Lukic B; Davidovic L
    Eur J Vasc Endovasc Surg; 2021 Feb; 61(2):258-269. PubMed ID: 33334672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between omentin-1 and major cardiovascular events after lower extremity endovascular revascularization in diabetic patients: a prospective cohort study.
    Biscetti F; Nardella E; Rando MM; Cecchini AL; Angelini F; Cina A; Iezzi R; Filipponi M; Santoliquido A; Pitocco D; Landolfi R; Flex A
    Cardiovasc Diabetol; 2020 Oct; 19(1):170. PubMed ID: 33028322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ambulatory Status Over Time after Revascularization in Patients with Chronic Limb-Threatening Ischemia.
    Kodama A; Takahara M; Iida O; Soga Y; Terashi H; Kawasaki D; Izumi Y; Mii S; Komori K; Azuma N
    J Atheroscler Thromb; 2022 Jun; 29(6):866-880. PubMed ID: 34039832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adherence to lipid management guidelines is associated with lower mortality and major adverse limb events in patients undergoing revascularization for chronic limb-threatening ischemia.
    O'Donnell TFX; Deery SE; Darling JD; Shean KE; Mittleman MA; Yee GN; Dernbach MR; Schermerhorn ML
    J Vasc Surg; 2017 Aug; 66(2):572-578. PubMed ID: 28506476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness and Safety of Ultrasound Guided Lower Extremity Nerve Blockade in Infragenicular Bypass Grafting for High Risk Patients With Chronic Limb Threatening Ischaemia.
    Kikuchi S; Yamaguchi T; Miyake K; Uchida D; Koya A; Iida T; Kurosawa A; Sasakawa T; Kunisawa T; Azuma N
    Eur J Vasc Endovasc Surg; 2019 Aug; 58(2):206-213. PubMed ID: 31272780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of the no-option foot: Deep vein arterialization.
    Ilyas S; Powell RJ
    Semin Vasc Surg; 2022 Jun; 35(2):210-218. PubMed ID: 35672111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of homocysteine levels on mortality risk in patients with chronic limb-threatening ischemia undergoing revascularization.
    Takahara M; Iida O; Soga Y; Kodama A; Terashi H; Azuma N
    Heart Vessels; 2021 Dec; 36(12):1825-1829. PubMed ID: 34131779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of Lower Extremity Endovascular Revascularization: Potential Predictors and Prevention Strategies.
    Biscetti F; Nardella E; Rando MM; Cecchini AL; Gasbarrini A; Massetti M; Flex A
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative 12-Month Outcomes of Drug-Coated Balloon Versus Non-Drug-Coated Balloon Revascularization Strategy in Chronic Limb-Threatening Ischemia: Results From the XLPAD Registry.
    Giannopoulos S; Jeon-Slaughter H; Kahlon RS; Tejani I; Baskar A; Banerjee S; Armstrong EJ
    Cardiovasc Revasc Med; 2020 Oct; 21(10):1276-1284. PubMed ID: 32249170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Editor's Choice - Impact of Comorbidity, Medication, and Gender on Amputation Rate Following Revascularisation for Chronic Limb Threatening Ischaemia.
    Baubeta Fridh E; Andersson M; Thuresson M; Sigvant B; Kragsterman B; Johansson S; Hasvold P; Nordanstig J; Falkenberg M
    Eur J Vasc Endovasc Surg; 2018 Nov; 56(5):681-688. PubMed ID: 30093176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial dysfunction in calf muscles of patients with combined peripheral arterial disease and diabetes type 2.
    Lindegaard Pedersen B; Bækgaard N; Quistorff B
    Int Angiol; 2017 Oct; 36(5):482-495. PubMed ID: 28291304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple Reinterventions for Claudication are Associated with Progression to Chronic Limb-Threatening Ischemia.
    Kim TI; Kiwan G; Mohamedali A; Zhang Y; Dardik A; Guzman RJ; Ochoa Chaar CI
    Ann Vasc Surg; 2021 Apr; 72():166-174. PubMed ID: 33227462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of time interval between endovascular intervention and free flap transfer on flap outcomes in critical limb-threatening ischemia: A retrospective analysis of 64 consecutive cases.
    Hahn HM; Lee DH; Lee IJ
    J Plast Reconstr Aesthet Surg; 2021 Jul; 74(7):1544-1552. PubMed ID: 33454224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.